Time course of lamotrigine de-induction: impact of step-wise withdrawal of carbamazepine or phenytoin (Q44036806)

29 November 2017

title

Time course of lamotrigine de-induction: impact of step-wise withdrawal of carbamazepine or phenytoin (English)

1 reference

29 November 2017

1 reference

1 reference

4

Frank G Gilliam

1 reference

29 November 2017

Gail D Anderson

1

1 reference

29 November 2017

Barry E Gidal

series ordinal

2

1 reference

29 November 2017

John A Messenheimer

series ordinal

3

1 reference

29 November 2017

publication date

1 May 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

49

1 reference

29 November 2017

issue

3

1 reference

29 November 2017

page(s)

211-217

1 reference

Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900033-5

7 January 2021

The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900033-5

7 January 2021

Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900033-5

7 January 2021

Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900033-5

7 January 2021

Effect of age and gender on disposition of temazepam

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900033-5

7 January 2021

An active-control trial of lamotrigine monotherapy for partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900033-5

7 January 2021

Population pharmacokinetics of lamotrigine adjunctive therapy in adults with epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900033-5

7 January 2021

Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring data

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900033-5

7 January 2021

Sex-difference and the effects of smoking and oral contraceptive steroids on the kinetics of diflunisal

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900033-5

7 January 2021

Influence of sex and oral contraceptive steroids on paracetamol metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900033-5

7 January 2021

Clinical Implications of Enzyme Induction and Enzyme Inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900033-5

7 January 2021

Effect of the removal of individual antiepileptic drugs on antipyrine kinetics, in patients taking polytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900033-5

7 January 2021

Pharmacokinetics and safety of lamotrigine (Lamictal) in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900033-5

7 January 2021

Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900033-5

7 January 2021

Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900033-5

7 January 2021

Influence of concurrent antiepileptic medication on the pharmacokinetics of lamotrigine as add-on therapy in epileptic children

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900033-5

7 January 2021

10.1016/S0920-1211(02)00033-5

Identifiers

DOI

1 reference

29 November 2017

1 reference